Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multi-canceR Early-detection and interVENTional Study in Asymptomatic Individuals: PREVENT

NCT05227534 is registered in ClinicalTrials.gov with Guangzhou Burning Rock Dx Co., Ltd. as lead sponsor.

NCT NCT05227534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05227534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multi-canceR Early-detection and interVENTional Study in Asymptomatic Individuals: PREVENT
Lead sponsor
Guangzhou Burning Rock Dx Co., Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2022
Completion date
December 31, 2028
Enrollment
12,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, circulating cell-free dna, early detection of cancer